Editorial overview - Embracing complexity in drug discovery
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Current opinion in drug discovery & development - 10(2007), 3, Seite 252-253 |
| Beteiligte Personen: |
Grund, Peter [VerfasserIn] |
|---|
| BKL: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1807645290 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1807645290 | ||
| 003 | DE-627 | ||
| 005 | 20230516115928.0 | ||
| 007 | tu | ||
| 008 | 090114s2007 xx ||||| 00| ||und c | ||
| 035 | |a (DE-627)OLC1807645290 | ||
| 035 | |a (DE-599)GBVOLC1807645290 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Grund, Peter |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Editorial overview - Embracing complexity in drug discovery |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Maliski, Ed |4 oth | |
| 700 | 1 | |a Brown, Frank |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in drug discovery & development |d London : Thomson Scientific, 1998 |g 10(2007), 3, Seite 252-253 |w (DE-627)253542618 |w (DE-600)1461136-3 |w (DE-576)43551587X |x 1367-6733 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2007 |g number:3 |g pages:252-253 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4027 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 10 |j 2007 |e 3 |h 252-253 | ||